Lieff Cabraser Civil Justice Blog

Sarah London Appointed to Plaintiffs’ Executive Committee in Gilead HIV Drug Kidney & Bone Injuries Litigation

Sarah London Appointed to Plaintiffs' Executive Committee in Gilead HIV Drug Kidney & Bone Injuries Litigation

On February 5, 2020, Judge Andrew Y.S. Cheng of the Superior Court for the County of San Francisco issued an order appointing Lieff Cabraser partner Sarah R. London  to the Plaintiffs’ Executive Committee in the Gilead HIV Drug Kidney & Bone Injuries Litigation. Sarah will lead the litigation on behalf of patients across California who allege they suffered kidney and bone injuries from HIV drugs made and distributed by pharmaceutical giant Gilead Sciences, Inc. [Read more…]

Geron Investor A­­lert:  March 23, 20­­­20 Filing Deadline in Class Action – Contact Lieff Cabraser

generic securities image

Lieff Cabraser  announces that class action litigation has been filed on behalf of investors who purchased shares of the common stock of Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) between March 19, 2018 and September 26, 2018, inclusive (the “Class Period”). [Read more…]

Lieff Cabraser Files California Wrongful Death Case Against Alkermes Over Vivitrol Opioid Dependence Drug

Hospital

Lawsuit alleges defects and fraudulent misrepresentation of Vivitrol/Naltrexone Led to overdose death of 26-year-old Clayton Stafford after two years of Vivitrol use

February 4, 2020—(LOS ANGELES)—Lieff Cabraser has filed a wrongful death lawsuit against biopharmaceutical manufacturer Alkermes, Inc. on behalf of the family of California resident Clayton Stafford relating to Clayton’s mandated prescription use of Vivitrol that led to a tragic and preventable opioid overdose in February 2018. The lawsuit alleges that Clayton, his parents, his rehabilitation counselors, and healthcare providers were misled into believing that Vivitrol would be an appropriate solution for the treatment of his opioid addiction, and that if defendants properly marketed and warned about the limitations of Vivitrol, Clayton would not have used the drug that led to his death. [Read more…]

Mohawk Shareholder Alert:  March 3, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

securities

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased shares of the common stock of Mohawk Industries, Inc. (“Mohawk” or the “Company”) (NYSE: MHK) between April 28, 2017 and July 25, 2019, inclusive (the “Class Period”). [Read more…]

Daniel Chiplock Co-Authors Piece in Support of the SEC’s Continued Use of Disgorgement for the Harvard Law School Forum on Corporate Governance

Daniel Chiplock Co-Writes Essay in Support of SEC Disgorgement Power

Lieff Cabraser partner Daniel P. Chiplock, along with Tyler Gellasch of the Healthy Markets Association and Andy Green of the Center for American Progress, wrote a piece published by the Harvard Law School Forum on Corporate Governance in support of the Securities & Exchange Commission’s continued ability to compel disgorgement as a remedy in financial fraud cases. The Supreme Court is set to hear oral argument in March on whether the SEC may continue seeking disgorgement,  compelling giving-up of all ill-gotten gains—in civil enforcement proceedings. [Read more…]

Johnson & Johnson Ordered to Pay $344 Million for Selling Transvaginal Mesh Implants Despite Known Health Risks

generic mesh

As reported by Law360 (subscription), a California federal judge has ruled that Johnson & Johnson must pay nearly $344 million in civil penalties for misleading consumers about the true health risks associated with its pelvic mesh products. The trailblazing suit was brought by California’s attorney general, Xavier Becerra, who in a statement touting the judge’s decision said that “J&J knew of the dangers of its mesh products but had prioritized its profits over women’s health.” [Read more…]

Jonathan Selbin Talks to Consumer Reports About Forced Arbitration

Jonathan Selbin Talks to Consumer Reports About Forced Arbitration

Consumer Reports has published an in-depth article on forced arbitration, uncovering the devastating negative impact it has had on the rights of American consumers by limiting their options to seek justice and compensation when products turn out to be faulty or harmful. [Read more…]

Lieff Cabraser donates goods to Youth Villages of Middle Tennessee

Lieff Cabraser donates goods to Youth Villages of Middle Tennessee

Lieff Cabraser is proud to announce that it has organized an office building-wide drive to collect much-needed household goods for children in need at Youth Villages of Middle Tennessee. The successful drive resulted in the donation of several truckloads of goods including household items, clothing, books, and games. Youth Villages is a national organization that provides support for children and young people who face difficulty in emotional, mental, and behavioral areas. [Read more…]

Ohio Judge Denies Pharmacies Attempt to Escape Public Nuisance In Opioid MDL

Ohio Federal Judge Indicating Support for “Negotiation Class” in Opioid MDL

As reported by Law360 (subscription), an Ohio federal judge has denied attempts by Rite Aid, Walmart and other pharmacies to dismiss claims alleging their opioid monitoring systems were not reliable and that their failure to stop opioids from being obtained illegally created a public nuisance. [Read more…]

New York 2019 Child Victims Act – Take Action to Get Justice Before the August 14, 2020 Deadline

Abuse Survivors Can Receive Compensation

New York State recently enacted the New York Child Victims Act, which opens a one-year window until August 14, 2020 for people of any age who experienced sexual abuse as a child to bring lawsuits in New York even for abuse that occurred decades ago. Going forward, the new law also allows child sex abuse survivors to bring a civil lawsuit against abusers and institutions that protected them until the survivor reaches the age of 55.
[Read more…]

Lieff Cabraser Announces Notice of Settlement for Anticoagulant Medications Lovenox® and Generic Enoxaparin

White pharmaceutical pills spilling from prescription bottle

If You Bought or Provided Reimbursement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin Between September 21, 2011 and September 30, 2015 You Could Get Money from Class Action Settlements Totaling $120 Million

Proposed Settlements totaling $120 million have been reached in a class action lawsuit regarding the price that uninsured consumers, hospitals, and third-party payors paid for Lovenox® or generic enoxaparin. The lawsuit asserts that Defendants kept the prices of Lovenox® and generic enoxaparin higher than they otherwise would have been by manipulating the generic approval process. Defendants deny any wrongdoing. [Read more…]

David Stellings Discusses Plaintiff Perspectives on Multidistrict Litigation at University of Miami School of Law Class Action Forum

David Stellings Discusses Plaintiff Perspectives on Multidistrict Litigation at University of Miami School of Law Class Action Forum

On January 24, 2020, Lieff Cabraser partner David S. Stellings spoke at The University of Miami School of Law’s 2020 “Class Action & Complex Litigation Forum.” David and several other legal experts were featured on the panel “MDL—Who Wants One? Plaintiff, Defense and Judicial Perspectives on MDL Pros and Cons.” [Read more…]

Abby Wolf to Discuss Public Nuisance Law and Its Impact on the Opioid Litigation at Upcoming ABA Conference in Colorado

Abby Wolf ABA Conference Colorado

Lieff Cabraser attorney Abby R. Wolf will be speaking at the American Bar Association’s 2020 Environmental & Energy, Mass Torts, and Products Liability Litigation Committees’ Joint Regional CLE Program taking place from January 29-31, 2020 at The Westin Snowmass Resort in Colorado. Abby will be featured on the panel “Mass Torts Committee Breakout: Public Nuisance Law and Its Impact on the Opioid Litigation and Future Mass Torts” on Friday, January 31st from 10:30-11:30am. [Read more…]

Lieff Cabraser Files Amicus Brief in U.S. Supreme Court Supporting the SEC’s Ability to Seek Disgorgement of Gains from Securities Law Violations in Federal Court

U.S. Supreme Court

Lieff Cabraser today filed an amicus brief in the U.S. Supreme Court arguing for the importance of the ability of the Securities and Exchange Commission to continue to seek disgorgement of the gains from securities law violations in federal court in order to effectively deter securities fraud and promote the public policies that form the foundation of U.S. securities laws. [Read more…]

Plaintiffs Defeat Motion to Dismiss Lawsuit Alleging FINA International Swim Organization Uses Market Dominance to Extract Enormous Revenues from World’s Best Swimmers

Woman swimming in pool

On January 21, 2020, U.S. Magistrate Judge Jacqueline Scott Corley issued an order denying the motion of defendant international swim organization Fédération Internationale de Natation (“FINA”) to dismiss the lawsuit alleging that FINA leverages its market dominance to extract – and largely keep for itself – enormous revenues from the labor of the world’s best swimmers. [Read more…]

Annika K. Martin to Discuss the USC Tyndall Sexual Abuse Class Action Lawsuit at Berkeley Law

Annika K. Martin to Discuss the USC Tyndall Sexual Abuse Class Action Lawsuit at Berkeley Law

On Thursday, January 23, 2020, from 12:40 – 2:00 p.m., Lieff Cabraser partner Annika K. Martin will speak at Berkeley Law’s Lunch Talk event on the USC Tyndall Sex Abuse Litigation, in which Ms. Martin represents women who were sexually abused, harassed, and molested by former head USC gynecologist George Tyndall, M.D. while they were students at the University of Southern California. Ms. Martin will explore the class action lawsuit and discuss how the recent $250 million settlement represents an important step forward for survivors. [Read more…]

Elizabeth Cabraser, Paulina do Amaral, and Annika K. Martin to Serve as Faculty in March 2020 Duke University Mass Tort MDL Certificate Program

Elizabeth Cabraser, Paulina do Amaral, and Annika K. Martin to Serve as Faculty in March 2020 Duke University Mass Tort MDL Certificate Program

The Duke Law School Bolch Judicial Institute is holding an intensive 3-day mass-tort MDL instructional program from March 11-13, 2020. Faculty will include two Duke Law professors, six experienced MDL judges, and 25 lawyers who have either served as preeminent mass-tort lead counsel or chaired specific-task MDL committees. The program is designed for both plaintiff and defense lawyers looking to transition into the tort and consumer mass-tort field who would like to enhance their ability to compete for MDL committee appointments, and for those more experienced attorneys focused on refining their skills in the field. [Read more…]